KRAS and acute myeloid leukemia: The multivariate model of the complete cohort with AML identified that KRAS mutations were independent predictors of poor survival and remained independent prognostic significance in pediatric 11q23/KMT2A‐rearranged AML after adjustment for other risk factors.